MSB 2.03% $1.45 mesoblast limited

2024 Here we go again., page-482

  1. 594 Posts.
    lightbulb Created with Sketch. 289
    give us our approval for sr aGVHD in paediatrics and that will do me for now... followed by an AA IN ADULTS with a confirmatory phase 3. trial with a relatively quick roll out... and a little good news ( update due shortly)for our amazing results from the recent results of rexlemestrocel in babies with serious heat condition ...

    that would be enough for me right now
    Last edited by googala: 17/04/24
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.